The Middle East & Africa Cancer Vaccines Market was valued at US$ 252.46 million in 2019 and is projected to reach US$ 779.60 million by 2027; it is expected to grow at a CAGR of 15.5% during the forecast period.
The growth of the Middle East & Africa Cancer Vaccines market is mainly attributed to the growing prevalence of cancer andinitiatives taken by global health organization.Saudi Arabia is one of the important countries in the Middle Eastern region that has significant scope for the cancer vaccines market. The healthcare system in the country is developing at rapid pace as well as increasing number of international companies are developing medical and research team in the country. A sharp increase in the state health budget is also expected to drive the growth of cancer vaccines market in the country.
Saudi Arabia Cancer Vaccines Market Revenue and Forecast to 2027 (US$ Million)
MIDDLE EAST & AFRICACANCER VACCINES – MARKET SEGMENTATION
By Technology
- Dendritic Cells Cancer Vaccines
- Recombinant Cancer Vaccines
- Antigen Cancer Vaccines
- Whole Cell Cancer Vaccines
- Viral Vector Cancer Vaccines
By Type
- Preventive Cancer Vaccines
- Therapeutic Cancer Vaccine
By Indication
- Cervical Cancer
- Prostate Cancer
- Other Indications
By End Use
- Pediatrics
- Adults
By Country
- Saudi Arabia
- South Africa
- UAE
CompanyProfiles
- AstraZeneca
- GlaxoSmithKline plc.
- Aduro Biotech Inc
- Pfizer Inc.
- Sanofi
- Bristol-Myers Squibb
- Moderna, Inc.
- OncBioMune Pharmaceuticals Inc.
- MaxiVAX
- Nouscom
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Technology, Type, Indication, End User, and Country
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
Saudi Arabia
INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Cancer Vaccines Market - By Technology
1.3.2 Cancer Vaccines Market - By Type
1.3.3 Cancer Vaccines Market - By Indication
1.3.4 Cancer Vaccines Market - By End User
1.3.5 Cancer Vaccines Market - By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. CANCER VACCINES MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 MIDDLE EAST AND AFRICA - Pest Analysis
4.3. EXPERT OPINIONS
5. CANCER VACCINES MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. CANCER VACCINES MARKET - MIDDLE EAST AND AFRICA MARKET ANALYSIS
6.1. CANCER VACCINES - MIDDLE EAST AND AFRICA MARKET OVERVIEW
6.2. CANCER VACCINES - MIDDLE EAST AND AFRICA MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. CANCER VACCINES MARKET - REVENUE AND FORECASTS TO 2027 – TECHNOLOGY
7.1. OVERVIEW
7.2. TECHNOLOGY MARKET FORECASTS AND ANALYSIS
7.3. DENDRITIC CELLS CANCER VACCINES
7.3.1. Overview
7.3.2. Dendritic Cells Cancer Vaccines Market Forecast and Analysis
7.4. RECOMBINANT CANCER VACCINES
7.4.1. Overview
7.4.2. Recombinant Cancer Vaccines Market Forecast and Analysis
7.5. ANTIGEN CANCER VACCINES
7.5.1. Overview
7.5.2. Antigen Cancer Vaccines Market Forecast and Analysis
7.6. WHOLE CELL CANCER VACCINES
7.6.1. Overview
7.6.2. Whole Cell Cancer Vaccines Market Forecast and Analysis
7.7. VIRAL VECTOR CANCER VACCINES
7.7.1. Overview
7.7.2. Viral Vector Cancer Vaccines Market Forecast and Analysis
8. CANCER VACCINES MARKET - REVENUE AND FORECASTS TO 2027 – TYPE
8.1. OVERVIEW
8.2. TYPE MARKET FORECASTS AND ANALYSIS
8.3. PREVENTIVE CANCER VACCINES
8.3.1. Overview
8.3.2. Preventive Cancer Vaccines Market Forecast and Analysis
8.4. THERAPEUTIC CANCER VACCINES
8.4.1. Overview
8.4.2. Therapeutic Cancer Vaccines Market Forecast and Analysis
9. CANCER VACCINES MARKET - REVENUE AND FORECASTS TO 2027 – INDICATION
9.1. OVERVIEW
9.2. INDICATION MARKET FORECASTS AND ANALYSIS
9.3. CERVICAL CANCER
9.3.1. Overview
9.3.2. Cervical Cancer Market Forecast and Analysis
9.4. PROSTATE CANCER
9.4.1. Overview
9.4.2. Prostate Cancer Market Forecast and Analysis
9.5. OTHER INDICATIONS
9.5.1. Overview
9.5.2. Other Indications Market Forecast and Analysis
10. CANCER VACCINES MARKET - REVENUE AND FORECASTS TO 2027 – END USER
10.1. OVERVIEW
10.2. END USER MARKET FORECASTS AND ANALYSIS
10.3. PEDIATRICS
10.3.1. Overview
10.3.2. Pediatrics Market Forecast and Analysis
10.4. ADULTS
10.4.1. Overview
10.4.2. Adults Market Forecast and Analysis
11. CANCER VACCINES MARKET REVENUE AND FORECASTS TO 2027 – COUNTRY ANALYSIS
- 11.1 MIDDLE EAST AND AFRICA CANCER VACCINES MARKET OVERVIEW
- 11.2 MIDDLE EAST AND AFRICA CANCER VACCINES MARKET FORECASTS AND ANALYSIS
- 11.3 MIDDLE EAST AND AFRICA Cancer Vaccines Market FORECASTS AND ANALYSIS - BY COUNTRIES
11.3.1 UAE Cancer Vaccines Market
- 11.3.1.1 UAE Cancer Vaccines Market by Technology
- 11.3.1.2 UAE Cancer Vaccines Market by Type
- 11.3.1.3 UAE Cancer Vaccines Market by Indication
- 11.3.1.4 UAE Cancer Vaccines Market by End User
11.3.2 Saudi Arabia Cancer Vaccines Market
- 11.3.2.1 Saudi Arabia Cancer Vaccines Market by Technology
- 11.3.2.2 Saudi Arabia Cancer Vaccines Market by Type
- 11.3.2.3 Saudi Arabia Cancer Vaccines Market by Indication
- 11.3.2.4 Saudi Arabia Cancer Vaccines Market by End User
11.3.3 South Africa Cancer Vaccines Market
- 11.3.3.1 South Africa Cancer Vaccines Market by Technology
- 11.3.3.2 South Africa Cancer Vaccines Market by Type
- 11.3.3.3 South Africa Cancer Vaccines Market by Indication
- 11.3.3.4 South Africa Cancer Vaccines Market by End User
13. INDUSTRY LANDSCAPE
13.1. MERGERS AND ACQUISITIONS
13.2. AGREEMENTS, COLLABORATIONS AND JOINT VENTURES
13.3. NEW PRODUCT LAUNCHES
13.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
14. CANCER VACCINES MARKET, KEY COMPANY PROFILES
14.1. ASTRAZENECA
14.1.1. Key Facts
14.1.2. Business Description
14.1.3. Products and Services
14.1.4. Financial Overview
14.1.5. SWOT Analysis
14.1.6. Key Developments
14.2. GLAXOSMITHKLINE PLC.
14.2.1. Key Facts
14.2.2. Business Description
14.2.3. Products and Services
14.2.4. Financial Overview
14.2.5. SWOT Analysis
14.2.6. Key Developments
14.3. ADURO BIOTECH INC
14.3.1. Key Facts
14.3.2. Business Description
14.3.3. Products and Services
14.3.4. Financial Overview
14.3.5. SWOT Analysis
14.3.6. Key Developments
14.4. PFIZER INC.
14.4.1. Key Facts
14.4.2. Business Description
14.4.3. Products and Services
14.4.4. Financial Overview
14.4.5. SWOT Analysis
14.4.6. Key Developments
14.5. SANOFI
14.5.1. Key Facts
14.5.2. Business Description
14.5.3. Products and Services
14.5.4. Financial Overview
14.5.5. SWOT Analysis
14.5.6. Key Developments
14.6. BRISTOL-MYERS SQUIBB
14.6.1. Key Facts
14.6.2. Business Description
14.6.3. Products and Services
14.6.4. Financial Overview
14.6.5. SWOT Analysis
14.6.6. Key Developments
14.7. MODERNA, INC.
14.7.1. Key Facts
14.7.2. Business Description
14.7.3. Products and Services
14.7.4. Financial Overview
14.7.5. SWOT Analysis
14.7.6. Key Developments
14.8. ONCBIOMUNE PHARMACEUTICALS INC.
14.8.1. Key Facts
14.8.2. Business Description
14.8.3. Products and Services
14.8.4. Financial Overview
14.8.5. SWOT Analysis
14.8.6. Key Developments
14.9. MAXIVAX
14.9.1. Key Facts
14.9.2. Business Description
14.9.3. Products and Services
14.9.4. Financial Overview
14.9.5. SWOT Analysis
14.9.6. Key Developments
14.10. NOUSCOM
14.10.1. Key Facts
14.10.2. Business Description
14.10.3. Products and Services
14.10.4. Financial Overview
14.10.5. SWOT Analysis
14.10.6. Key Developments
15. APPENDIX
15.1. ABOUT THE INSIGHT PARTNERS
15.2. GLOSSARY OF TERMS
LIST OF TABLES
Table 1. Middle East & Africa Cancer Vaccines Market, by Type– Revenue and Forecast to 2027 (USD Million)
Table 2. Middle East & Africa Cancer Vaccines Market, by Indication – Revenue and Forecast to 2027 (USD Million)
Table 3. Middle East & Africa Cancer Vaccines Market, by Technology– Revenue and Forecast to 2027 (USD Million)
Table 4. Middle East & Africa Cancer Vaccines Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 5. Saudi Arabia Cancer Vaccines Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 6. Saudi Arabia Cancer Vaccines Market, by Indication – Revenue and Forecast to 2027 (USD Million)
Table 7. Saudi Arabia Cancer Vaccines Market, by Technology– Revenue and Forecast to 2027 (USD Million)
Table 8. Saudi Arabia Cancer Vaccines Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 9. UAE Cancer Vaccines Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 10. UAE Cancer Vaccines Market, by Indication – Revenue and Forecast to 2027 (USD Million)
Table 11. UAE Cancer Vaccines Market, by Technology– Revenue and Forecast to 2027 (USD Million)
Table 12. UAE Cancer Vaccines Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 13. South Africa Cancer Vaccines Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 14. South Africa Cancer Vaccines Market, by Indication – Revenue and Forecast to 2027 (USD Million)
Table 15. South Africa Cancer Vaccines Market, by Technology– Revenue and Forecast to 2027 (USD Million)
Table 16. South Africa Cancer Vaccines Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 17. Organic Developments Done By Companies
Table 18. Inorganic Developments Done By Companies
Table 19. Glossary of Terms, Cancer Vaccines Market
LIST OF FIGURES
Figure 1. Cancer Vaccines Market Segmentation
Figure 2. Cancer Vaccines Market Segmentation, By Region
Figure 3. Cancer Vaccines Market Overview
Figure 4. Recombinant Cancer Vaccines Segment Held Largest Share of Cancer Vaccines Market
Figure 5. MEA Cancer Vaccines market, Industry Landscape
Figure 6. Middle East and Africa (MEA) PEST Analysis
Figure 7. Cancer Statistics, 2020
Figure 8. Cancer Vaccines Market Impact Analysis of Driver and Restraints
Figure 9. Cancer Vaccines Market, by Technology, 2019 and 2027 (%)
Figure 10. Dendritic Cells Cancer Vaccines : Cancer Vaccines Market – Revenue and Forecast to 2027 (US$ Million)
Figure 11. Recombinant Cancer Vaccines: Cancer Vaccines Market – Revenue and Forecast to 2027 (US$ Million)
Figure 12. Antigen Cancer Vaccines: Cancer Vaccines Market – Revenue and Forecast to 2027 (US$ Million)
Figure 13. Whole Cell Cancer Vaccines: Cancer Vaccines Market – Revenue and Forecast to 2027 (US$ Million)
Figure 14. Viral Vector Cancer Vaccines: Cancer Vaccines Market – Revenue and Forecast to 2027 (US$ Million)
Figure 15. Cancer Vaccines Market Revenue Share, by Type (2019 and 2027)
Figure 16. Preventive Cancer Vaccines: Cancer Vaccines Market – Revenue and Forecast to 2027 (US$ Million)
Figure 17. Therapeutic Cancer Vaccines: Cancer Vaccines Market – Revenue and Forecast to 2027 (US$ Million)
Figure 18. Cancer Vaccines Market Revenue Share, by Indication (2019 and 2027)
Figure 19. Cervical Cancer: Cancer Vaccines Market – Revenue and Forecast to 2027 (US$ Million)
Figure 20. Prostate Cancer: Cancer Vaccines Market – Revenue and Forecast to 2027 (US$ Million)
Figure 21. Other Indications: Cancer Vaccines Market – Revenue and Forecast to 2027 (US$ Million)
Figure 22. Cancer Vaccines Market Revenue Share, by End Use (2019 and 2027)
Figure 23. Pediatrics: Cancer Vaccines Market – Revenue and Forecast to 2027 (US$ Million)
Figure 24. Adults: Cancer Vaccines Market – Revenue and Forecast to 2027 (US$ Million)
Figure 25. Middle East & Africa: Cancer Vaccines Market, by Key Country – Revenue (2019) (USD Million)
Figure 26. Middle East & Africa Cancer Vaccines Market Revenue and Forecast to 2027 (USD Million)
Figure 27. Middle East & Africa: Cancer Vaccines Market Share by Country – 2019 & 2027, (%)
Figure 28. Saudi Arabia: Cancer Vaccines Market – Revenue and Forecast to 2027 (USD Million)
Figure 29. UAE: Cancer Vaccines Market – Revenue and Forecast to 2027 (US$ Million)
Figure 30. South Africa: Cancer Vaccines Market – Revenue and Forecast to 2027 (USD Million)
Figure 31. Impact of COVID-19 Pandemic in Rest of World Country Markets
Figure 32. Growth Strategies Done by the Companies in the Market, (%)
The List of Companies - Middle East & Africa Cancer Vaccines Market
- AstraZeneca
- GlaxoSmithKline plc.
- Aduro Biotech Inc
- Pfizer Inc.
- Sanofi
- Bristol-Myers Squibb
- Moderna, Inc.
- OncBioMune Pharmaceuticals Inc.
- MaxiVAX
- Nouscom
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Trends and growth analysis reports related to Middle East and Africa Cancer Vaccines Market
Oct 2020
Aquatic Veterinary Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Diagnostics and Treatments), Species (Fish, Crustaceans, Mollusca, and Others), Disease Source (Bacteria, Viruses, Parasites, and Others), Route of Administration (Water Medication, Medicated Feed, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Oct 2020
Sickle Cell Disease Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis By Treatment (Generic Drugs and Originators), Route of Administration (Oral and Parenteral), and Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)
Oct 2020
Malaria and Sickle Cell Disease Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Treatment [Malaria and Sickle Cell Disease (SCD)], Route of Administration (Oral and Parenteral), and Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)
Oct 2020
Pharmaceutical Contract Sales Organizations Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Services (Commercial Services and Non-Commercial Services), Modules (Syndicated Modules and Dedicated Modules), Therapeutic Area (Cardiovascular Disorders, Oncology, Metabolic Disorders, Neurology, Orthopedic Diseases, Infectious Diseases, and Others), End User (Biopharmaceutical Companies and Pharmaceutical Companies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Oct 2020
Breast Cancer Therapeutics Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Drug Therapy [Targeted Drug Therapy (Abemaciclib, Ado-Trastuzumab Emtansine, Palbociclib, Trastuzumab, and Other Target Drug Therapies), Hormonal Drug Therapy (Selective Estrogen Receptor Modulators, Aromatase Inhibitors, and Selective Estrogen Receptor Downregulators), Chemotherapy, and Immunotherapy/Biological Therapy], Breast Cancer Type (Hormone Receptor, HER2+, and Triple-Negative Breast Cancer), Distribution Channel (Hospital Pharmacies, Drug Stores and Retail Pharmacies, and Online Pharmacies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Oct 2020
Radioactive Tracer Market
Size and Forecast to 2030 - Global Analysis by Tracer Type [Technetium-99m & Tc-97m, Iodine-131, Iron-59, Lutetium-171, Rubidium (Rb-82) Chloride & Ammonia (N-13), Scandium-46, Seaborgium-269, Hassium-269, Gallium Citrate Ga 67, Prostate-Specific Membrane Antigen (PSMA) (Ga-68), FDDNP (F-18) & FDOPA (F-18), Phosphorus-32 & Chromium-51, Thallium-201, F-18 FDG, F-18 FAPI, Ga-68 FAPI, F-18 PSMA, DOTATOC/DOTANOC/DOTATATE (Ga-68), and Others], Test Type (PET, SPECT, and Others), Application (Oncology, Pulmonary, Neurology, Cardiology, and Others) End User (Hospitals & Clinics, Diagnostic Centers, Academic & Research Institutes, And Others), and Geography
Oct 2020
Glioma Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Disease (Astrocytoma, Oligoastrocytoma, and Oligodendroglioma), Treatment Type (Surgery, Chemotherapy, Radiation Therapy, and Others), Grade (Low Grade and High Grade), End User (Hospital & Clinics and Ambulatory Surgical Center), and Geography
Oct 2020
Hyperpigmentation Disorder Treatment Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Treatment Type (Cosmeceutical, Light or Laser Therapy, Microdermabrasion, Chemical Peels, Cryotherapy, and Others), Condition (Melasma, Solar Lentigines, Post-Inflammatory Hyperpigmentation, and Others), End User (Hospitals, Dermatology Centers, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)